Neonatal development of the corneal stroma in wild-type and lumican-null mice

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 1, 2006, Pages 146-150

  Beecher, Nicola ^a   Chakravarti, Shukti ^b   Joyce, Sarah ^b   Meek, Keith M ^a   Quantock, Andrew J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBRIL; LUMICAN; FIBRILLAR COLLAGEN; KERATAN SULFATE; PROTEOCHONDROITIN SULFATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA STROMA; EXTRACELLULAR MATRIX; MOUSE; NEWBORN; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; SYNCHROTRON; X RAY DIFFRACTION; ANIMAL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; CORNEAL STROMA; EXTRACELLULAR MATRIX; FIBRILLAR COLLAGENS; KERATAN SULFATE; MICE; PROTEOCHONDROITIN SULFATES; X-RAY DIFFRACTION;

EID: 33644836062     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0907     Document Type: Article

References (28)

1. Maurice DM. The structure and transparency of the cornea. J Physiol. 1957;136:263-286.
2. Anseth A. Glycosaminoglycans in corneal regeneration. Exp Eye Res. 1961;1:122-127.
3. Hassell JR, Cintron C, Kublin C, Newsome DA. Proteoglycan changes during restoration of transparency in corneal scars. Arch Biochem Biophys. 1983;222:362-369.
4. Nakazawa K, Hassell JR, Hascall VC, Lohmander LS, Newsome DA, Krachmer J. Defective processing of keratan sulfate in macular corneal dystrophy. J Biol Chem. 1984;259:22:13751-13757.
5. Yang CJ, SundarRaj N, Thonar J-Ma, Klintworth GK. Immunohistochemical evidence of heterogeneity in macular corneal dystrophy. Am J Ophthalmol. 1988;106:65-71.
6. Quantock AJ, Meek KM, Ridgway AEA, Bron AJ, Thonar EJ-MA. Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing. Curr Eye Res. 1990;9:4:393-398.
7. Anseth A. Glycosaminoglycans in the developing corneal stroma. Exp Eye Res. 1961;1:116-121.
8. Cornuet PK, Blochberger TC, Hassell JR. Molecular polymorphism of lumican during corneal development. Invest Ophthalmol Vis Sci. 1994;35:870-877.
9. Connon CJ, Meek KM, Kinoshita S, Quantock AJ. Spatial and temporal alterations in the collagen fibrillar array during the onset of transparency in the avian cornea. Exp Eye Res. 2004;78:909-915.
10. Blochberger TC, Vergnes JP, Hempel J, Hassell JR. cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem. 1992;267:1:347-352.
11. Corpuz LM, Funderburgh JL, Funderburgh ML, Bottomley GS, Prakash S, Conrad GW. Molecular cloning and tissue distribution of keratocan: bovine corneal keratan sulfate proteoglycan 37A. J Biol Chem. 1996;271:16:9759-9763.
12. Funderburgh JL, Corpuz LM, Roth MR, Funderburgh ML, Tasheva ES, Conrad GW. Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. J Biol Chem. 1997;272:44:28089-28095.
13. Liu CY, Birk DE, Hassell JR, Kane B, Kao WWY. Keratocan-deficient mice display alterations in corneal structure. J Biol Chem. 2003;278:21672-21677.
14. Tasheva ES, Koester A, Paulson AQ, et al. Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol Vis. 2002;8:407-415.
15. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998;141:1277-1286.
16. Song J, Lee Y-G, Houston J, et al. Neonatal corneal stromal development in the normal and lumican-deficient mouse. Invest Ophthalmol Vis Sci. 2003;44:548-557.
17. Quantock AJ, Meek KM, Chakravarti S. An x-ray diffraction investigation of corneal structure in lumican-deficient mice. Invest Ophthalmol Vis Sci. 2001;42:1750-1756.
18. Meek KM, Quantock AJ, Boote C, Liu CY, Kao WWY. An x-ray investigation of corneal structure in keratocan-deficient mice. Matrix Biol. 2003;22:467-475.
19. Beecher N, Carlson C, Allen BR, et al. An x-ray diffraction study of corneal structure in mimecan-deficient mice. Invest Ophthalmol Vis Sci. 2005;46:4046-4049.
20. Meek KM, Quantock AJ. The use of x-ray scattering techniques to determine corneal ultrastructure. Prog Ret Eye Res. 2001;20:95-137.
21. Stokes AR. The theory of x-ray fibre diagrams. Prog Biophys. 1955;5:5-167.
22. Regini JW, Elliott GF, Hodson SA. The ordering of corneal collagen fibrils with increasing ionic strength. J Mol Biol. 2004;336:179-186.
23. Benedek GB. Theory of transparency of the eye. Applied Optics. 1971;10:3:459-473.
24. Young RD, Tudor D, Hayes AJ, et al. Atypical composition and ultrastructure of proteoglycans in the mouse corneal stroma. Invest Ophthalmol Vis Sci. 2005;1973-1978.
25. Fullwood NJ, Meek KM. A synchrotron x-ray study of the changes occurring in the corneal stroma during processing for electron microscopy. J Microsc. 1992;169:53-60.
26. Chakravarti S, Petroll WM, Hassell JR, et al. Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. Invest Ophthalmol Vis Sci. 2000;41:11:3365-3373.
27. Rada JA, Cornuet PK, Hassell JR. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res. 1993;56:635-648.
28. Birk DE, Fitch JM, Babiarz JP, Doane KJ, Linsenmayer TF. Collagen fibrillogenesis in vitro - interaction of type-I and type-V collagen regulates fibril diameter. J Cell Sci. 1990;95:649-657.